TCW Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-15,643
Closed -$1.55M 315
2019
Q3
$1.55M Hold
15,643
0.02% 219
2019
Q2
$1.45M Sell
15,643
-11
-0.1% -$1.04K 0.02% 224
2019
Q1
$1.48M Sell
15,654
-401,811
-96% -$35.1M 0.01% 221
2018
Q4
$26.8M Sell
417,465
-240,870
-37% -$17.8M 0.28% 91
2018
Q3
$58.9M Sell
658,335
-482,145
-42% -$42.6M 0.48% 71
2018
Q2
$90.6M Sell
1,140,480
-61,541
-5% -$5.11M 0.73% 56
2018
Q1
$107M Sell
1,202,021
-173,687
-13% -$16.7M 0.87% 42
2017
Q4
$144M Sell
1,375,708
-230,294
-14% -$26M 1.16% 27
2017
Q3
$234M Sell
1,606,002
-41,310
-3% -$5.63M 1.86% 9
2017
Q2
$214M Sell
1,647,312
-73,451
-4% -$9M 1.78% 11
2017
Q1
$214M Sell
1,720,763
-382,333
-18% -$45.8M 1.79% 12
2016
Q4
$243M Sell
2,103,096
-92,067
-4% -$10.3M 1.83% 7
2016
Q3
$229M Buy
2,195,163
+36,389
+2% +$3.94M 1.74% 8
2016
Q2
$213M Buy
2,158,774
+100,726
+5% +$10.4M 1.61% 11
2016
Q1
$206M Buy
2,058,048
+131,833
+7% +$13.6M 1.51% 12
2015
Q4
$231M Sell
1,926,215
-16,525
-0.9% -$1.91M 1.66% 8
2015
Q3
$210M Sell
1,942,740
-21,751
-1% -$2.7M 1.51% 13
2015
Q2
$227M Sell
1,964,491
-382,579
-16% -$43.7M 1.46% 13
2015
Q1
$271M Sell
2,347,070
-462,969
-16% -$55.3M 1.3% 10
2014
Q4
$314M Buy
2,810,039
+18,810
+0.7% +$1.98M 1.32% 10
2014
Q3
$265M Buy
2,791,229
+55,213
+2% +$4.98M 1.06% 20
2014
Q2
$235M Sell
2,736,016
-214,392
-7% -$16.3M 0.97% 24
2014
Q1
$206M Buy
2,950,408
+164,180
+6% +$13M 0.86% 34
2013
Q4
$235M Buy
2,786,228
+124,006
+5% +$9.81M 0.99% 21
2013
Q3
$205M Buy
2,662,222
+307,526
+13% +$21.6M 0.95% 26
2013
Q2
$138M Buy
+2,354,696
New +$142M 0.68% 46

Other funds holding CELG

TCW Group's CELG Position: Q4 2019 in Review

TCW Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 15,643 shares — an estimated $1.55M sold.

TCW Group first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $314M in Q4 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • TCW Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • TCW Group sold 15,643 Celgene Corp shares in Q4 2019, an estimated $1.55M.
  • TCW Group first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • TCW Group's Celgene Corp position peaked at $314M in Q4 2014.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on TCW Group's 13F filing for Q4 2019, filed 10 Feb 2020.